540 related articles for article (PubMed ID: 32804155)
1. p53/microRNA-214/ULK1 axis impairs renal tubular autophagy in diabetic kidney disease.
Ma Z; Li L; Livingston MJ; Zhang D; Mi Q; Zhang M; Ding HF; Huo Y; Mei C; Dong Z
J Clin Invest; 2020 Sep; 130(9):5011-5026. PubMed ID: 32804155
[TBL] [Abstract][Full Text] [Related]
2. Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease.
Wang Y; Zheng ZJ; Jia YJ; Yang YL; Xue YM
J Transl Med; 2018 May; 16(1):146. PubMed ID: 29848325
[TBL] [Abstract][Full Text] [Related]
3. mTOR/ULK1 signaling axis mediated ultrashort wave regulation of autophagy to alleviate diabetic kidney disease.
Yan Y; Yu S; Fan Y
Adv Clin Exp Med; 2023 Nov; 32(11):1265-1277. PubMed ID: 37191448
[TBL] [Abstract][Full Text] [Related]
4. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
[TBL] [Abstract][Full Text] [Related]
5. KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathways.
Huang C; Lin MZ; Cheng D; Braet F; Pollock CA; Chen XM
Sci Rep; 2016 Mar; 6():23884. PubMed ID: 27029904
[TBL] [Abstract][Full Text] [Related]
6. Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.
Ma Z; Wei Q; Zhang M; Chen JK; Dong Z
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1822-F1832. PubMed ID: 30280598
[TBL] [Abstract][Full Text] [Related]
7. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
[TBL] [Abstract][Full Text] [Related]
9. Decreased secretion and profibrotic activity of tubular exosomes in diabetic kidney disease.
Wen J; Ma Z; Livingston MJ; Zhang W; Yuan Y; Guo C; Liu Y; Fu P; Dong Z
Am J Physiol Renal Physiol; 2020 Oct; 319(4):F664-F673. PubMed ID: 32715764
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy.
Deshpande SD; Putta S; Wang M; Lai JY; Bitzer M; Nelson RG; Lanting LL; Kato M; Natarajan R
Diabetes; 2013 Sep; 62(9):3151-62. PubMed ID: 23649518
[TBL] [Abstract][Full Text] [Related]
11. Short-Chain Fatty Acids Attenuate Renal Fibrosis and Enhance Autophagy of Renal Tubular Cells in Diabetic Mice Through the HDAC2/ULK1 Axis.
Ma X; Wang Q
Endocrinol Metab (Seoul); 2022 Jun; 37(3):432-443. PubMed ID: 35574586
[TBL] [Abstract][Full Text] [Related]
12. Geniposide Improves Diabetic Nephropathy by Enhancing ULK1-Mediated Autophagy and Reducing Oxidative Stress through AMPK Activation.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562139
[TBL] [Abstract][Full Text] [Related]
13. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
14. MiR-135a regulates renal fibrosis in rats with diabetic kidney disease through the Notch pathway.
Zhang LY; Wang Y; Yang YR; Shao JJ; Liang B
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1979-1987. PubMed ID: 32141566
[TBL] [Abstract][Full Text] [Related]
15. miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.
McClelland AD; Herman-Edelstein M; Komers R; Jha JC; Winbanks CE; Hagiwara S; Gregorevic P; Kantharidis P; Cooper ME
Clin Sci (Lond); 2015 Dec; 129(12):1237-49. PubMed ID: 26415649
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
Lo CS; Shi Y; Chenier I; Ghosh A; Wu CH; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Diabetes; 2017 Jul; 66(7):1964-1978. PubMed ID: 28424160
[TBL] [Abstract][Full Text] [Related]
17. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
[TBL] [Abstract][Full Text] [Related]
18. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-22 Promotes Renal Tubulointerstitial Fibrosis by Targeting PTEN and Suppressing Autophagy in Diabetic Nephropathy.
Zhang Y; Zhao S; Wu D; Liu X; Shi M; Wang Y; Zhang F; Ding J; Xiao Y; Guo B
J Diabetes Res; 2018; 2018():4728645. PubMed ID: 29850604
[TBL] [Abstract][Full Text] [Related]
20. miR-23a-3p regulates the inflammatory response and fibrosis in diabetic kidney disease by targeting early growth response 1.
Sheng S; Zou M; Yang Y; Guan M; Ren S; Wang X; Wang L; Xue Y
In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):763-774. PubMed ID: 34608568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
